DarioHealth extends Series B-3 mandatory conversion period and increases dividends

DarioHealth Corp.

Mandatory conversion period extended from 15 to 18 months from original issue date.
Dividends increased: 10% for fifth full quarter and 25% for sixth quarter from closing.
No additional securities were issued or sold as a result of the amendment.
Amendment effective September 11, 2024, approved by majority of preferred stock holders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.